Suppr超能文献

呼肠孤病毒:亦敌亦友

Reovirus: Friend and Foe.

作者信息

Eledge Michael R, Zita Marcelle Dina, Boehme Karl W

机构信息

Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, AR.

Center for Microbial Pathogenesis and Host Inflammatory Responses, University of Arkansas for Medical Sciences, Little Rock, AR.

出版信息

Curr Clin Microbiol Rep. 2019;6(3):132-138. doi: 10.1007/s40588-019-00121-8. Epub 2019 Jul 4.

Abstract

PURPOSE OF REVIEW

Mammalian orthoreovirus (reovirus) is a powerful tool for studying viral replication and pathogenesis. Most reovirus infections are subclinical, however recent work has catapulted reovirus into the clinical spotlight.

RECENT FINDINGS

Owing to its capacity to kill cancer cells more efficiently than normal cells, reovirus is under development as a therapeutic for a variety of cancers. New efforts have focused on genetically engineering reovirus to increase its oncolytic capacity, and determining how reovirus potentiates immunotherapy. Other recent studies highlight a potential role for reovirus in celiac disease (CeD). Using mouse models of CeD, reovirus caused loss of oral tolerance to dietary antigens, opening the possibility that reovirus could trigger CeD in humans.

SUMMARY

We will focus on new developments in reovirus oncolysis and studies suggesting a role for reovirus as a trigger for celiac disease (CeD) that make reovirus a potential friend and foe to human health.

摘要

综述目的

哺乳动物正呼肠孤病毒(呼肠孤病毒)是研究病毒复制和发病机制的有力工具。大多数呼肠孤病毒感染是亚临床的,然而最近的研究使呼肠孤病毒成为临床关注的焦点。

最新发现

由于呼肠孤病毒比正常细胞更有效地杀死癌细胞的能力,它正被开发用于治疗多种癌症。新的研究工作集中在对呼肠孤病毒进行基因工程改造以提高其溶瘤能力,以及确定呼肠孤病毒如何增强免疫疗法。其他近期研究突出了呼肠孤病毒在乳糜泻(CeD)中的潜在作用。利用CeD小鼠模型,呼肠孤病毒导致对饮食抗原的口服耐受性丧失,这表明呼肠孤病毒可能在人类中引发CeD。

总结

我们将关注呼肠孤病毒溶瘤的新进展以及表明呼肠孤病毒作为乳糜泻(CeD)触发因素的研究,这些研究使呼肠孤病毒成为对人类健康潜在的益友和敌人。

相似文献

1
Reovirus: Friend and Foe.
Curr Clin Microbiol Rep. 2019;6(3):132-138. doi: 10.1007/s40588-019-00121-8. Epub 2019 Jul 4.
3
Current understanding of reovirus oncolysis mechanisms.
Oncolytic Virother. 2018 Jun 14;7:53-63. doi: 10.2147/OV.S143808. eCollection 2018.
4
Immune-mediated antitumor activity of reovirus is required for therapy and is independent of direct viral oncolysis and replication.
Clin Cancer Res. 2009 Jul 1;15(13):4374-4381. doi: 10.1158/1078-0432.CCR-09-0334. Epub 2009 Jun 9.
5
Reovirus-Induced Apoptosis in the Intestine Limits Establishment of Enteric Infection.
J Virol. 2018 Apr 27;92(10). doi: 10.1128/JVI.02062-17. Print 2018 May 15.
7
Doxorubicin Conjugation to Reovirus Improves Oncolytic Efficacy in Triple-Negative Breast Cancer.
Mol Ther Oncolytics. 2020 Aug 21;18:556-572. doi: 10.1016/j.omto.2020.08.008. eCollection 2020 Sep 25.
10
The use of immunohistochemistry to determine oncolytic reovirus distribution and replication in-human tumors.
Methods. 2010 Dec;52(4):301-6. doi: 10.1016/j.ymeth.2010.08.011. Epub 2010 Aug 27.

引用本文的文献

1
3D Cryo-Correlative Methods to Study Virus Structure and Dynamics Within Cells.
Subcell Biochem. 2024;105:299-327. doi: 10.1007/978-3-031-65187-8_8.
2
From viral assembly to host interaction: AFM's contributions to virology.
J Virol. 2025 Jan 31;99(1):e0087324. doi: 10.1128/jvi.00873-24. Epub 2024 Dec 10.
3
Farmed fur animals harbour viruses with zoonotic spillover potential.
Nature. 2024 Oct;634(8032):228-233. doi: 10.1038/s41586-024-07901-3. Epub 2024 Sep 4.
5
Mammalian orthoreoviruses exhibit rare genotype variability in genome constellations.
Infect Genet Evol. 2023 Jun;110:105421. doi: 10.1016/j.meegid.2023.105421. Epub 2023 Mar 5.

本文引用的文献

1
Oncolytic viruses: how "lytic" must they be for therapeutic efficacy?
Oncoimmunology. 2019 Mar 28;8(6):e1581528. doi: 10.1080/2162402X.2019.1596006. eCollection 2019.
2
Live Imaging of Oncolytic Mammalian Orthoreovirus Expressing NanoLuc Luciferase in Tumor Xenograft Mice.
J Virol. 2019 Jun 28;93(14). doi: 10.1128/JVI.00401-19. Print 2019 Jul 15.
3
Interferons α and β in cancer: therapeutic opportunities from new insights.
Nat Rev Drug Discov. 2019 Mar;18(3):219-234. doi: 10.1038/s41573-018-0011-2.
4
Murine Norovirus Infection Induces T1 Inflammatory Responses to Dietary Antigens.
Cell Host Microbe. 2018 Nov 14;24(5):677-688.e5. doi: 10.1016/j.chom.2018.10.004. Epub 2018 Nov 1.
5
Going (Reo)Viral: Factors Promoting Successful Reoviral Oncolytic Infection.
Viruses. 2018 Aug 11;10(8):421. doi: 10.3390/v10080421.
6
Current understanding of reovirus oncolysis mechanisms.
Oncolytic Virother. 2018 Jun 14;7:53-63. doi: 10.2147/OV.S143808. eCollection 2018.
7
Talimogene laherparepvec: First in class oncolytic virotherapy.
Hum Vaccin Immunother. 2018 Apr 3;14(4):839-846. doi: 10.1080/21645515.2017.1412896. Epub 2018 Feb 22.
9
Tumour heterogeneity and resistance to cancer therapies.
Nat Rev Clin Oncol. 2018 Feb;15(2):81-94. doi: 10.1038/nrclinonc.2017.166. Epub 2017 Nov 8.
10
Microbes and Viruses Are Bugging the Gut in Celiac Disease. Are They Friends or Foes?
Front Microbiol. 2017 Aug 2;8:1392. doi: 10.3389/fmicb.2017.01392. eCollection 2017.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验